An ultraviolet photodetector with an active layer composed of solution processed polyfluorene:Zn0.71Cd0.29S hybrid nanomaterials

WOS: 000336525400031An ultraviolet photodetector with an active layer of solution processed polymer:quantum dot hybrid is introduced. Poly[9,9-di-(2-ethylhexyl)-fluoreny1-2,7-diy1] represents the polymer and ZI10.71 Cdo.29S is the quantum dot used for the device. Photophysical studies showed that an electron transfer from the polymer to the ternary quantum dot is thermodynamically favored. Quenching experiments performed between the polymer and quantum dot indicates the formation of a non-fluorescent complex with an association constant of 4.6 x 10(4)M(-1). The device structure of ITO/PEDOT:PSSIADS231BE: 50 wt% ZI10.71 Cd0.29S/A1 yielded a photoresponsivity value of 324 mAIIN at -4 V under 1 mIN/cm(2) illumination at 365 nm at room temperature and this value is further increased to 380 mAIIN as a result of annealing at 75 degrees C. (C) 2014 Elsevier B.V. All rights reserved.funds of Ege UniversityEge University [13GEE003]; state planning agencyTurkiye Cumhuriyeti Kalkinma BakanligiWe acknowledge the project support funds of Ege University (PC #: 13GEE003) and funds provided by the state planning agency for SO

Biofunctional quantum dots as fluorescence probe for cell-specific targeting

AbstractWe describe here the synthesis, characterization, bioconjugation, and application of water-soluble thioglycolic acid TGA-capped CdTe/CdS quantum dots (TGA-QDs) for targeted cellular imaging. Anti-human epidermal growth factor receptor 2 (HER2) antibodies were conjugated to TGA-QDs to target HER2-overexpressing cancer cells. TGA-QDs and TGA-QDs/anti-HER2 bioconjugates were characterized by fluorescence and UV–Vis spectroscopy, X-ray diffraction (XRD), hydrodynamic sizing, electron microscopy, and gel electrophoresis. TGA-QDs and TGA-QDs/anti-HER2 were incubated with cells to examine cytotoxicity, targeting efficiency, and cellular localization. The cytotoxicity of particles was measured using an MTT assay and the no observable adverse effect concentration (NOAEC), 50% inhibitory concentration (IC50), and total lethal concentration (TLC) were calculated. To evaluate localization and targeting efficiency of TGA-QDs with or without antibodies, fluorescence microscopy and flow cytometry were performed. Our results indicate that antibody-conjugated TGA-QDs are well-suited for targeted cellular imaging studies